000 | 01963 a2200529 4500 | ||
---|---|---|---|
005 | 20250517201409.0 | ||
264 | 0 | _c20180919 | |
008 | 201809s 0 0 eng d | ||
022 | _a1520-5762 | ||
024 | 7 |
_a10.1080/03639045.2018.1438460 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThondawada, Mahesh | |
245 | 0 | 0 |
_aAn effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. _h[electronic resource] |
260 |
_bDrug development and industrial pharmacy _cJul 2018 |
||
300 |
_a1120-1129 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xchemistry |
650 | 0 | 4 |
_aCD4 Antigens _xchemistry |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 |
_aDipeptidyl Peptidase 4 _xmetabolism |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xchemistry |
650 | 0 | 4 |
_aDrug Carriers _xchemistry |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
650 | 0 | 4 |
_aLactic Acid _xchemistry |
650 | 0 | 4 |
_aNanoparticles _xchemistry |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aPolyglycolic Acid _xchemistry |
650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
650 | 0 | 4 |
_aPolymers _xchemistry |
650 | 0 | 4 | _aRats |
700 | 1 | _aWadhwani, Ashish Devidas | |
700 | 1 | _aS Palanisamy, Dhanabal | |
700 | 1 | _aRathore, Hanumant Singh | |
700 | 1 | _aGupta, Ramesh C | |
700 | 1 | _aChintamaneni, Pavan Kumar | |
700 | 1 | _aSamanta, Malay K | |
700 | 1 | _aDubala, Anil | |
700 | 1 | _aVarma, Sameer | |
700 | 1 | _aKrishnamurthy, Praveen T | |
700 | 1 | _aGowthamarajan, Kuppusamy | |
773 | 0 |
_tDrug development and industrial pharmacy _gvol. 44 _gno. 7 _gp. 1120-1129 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/03639045.2018.1438460 _zAvailable from publisher's website |
999 |
_c28073723 _d28073723 |